Curio Announces new Scientific Advisory Board Members

We are excited to expand our Scientific Advisory Board and welcome new advisors. The deep and diverse scientific and real-world experience of our scientific advisors will help advance the company’s clinical, research, and development activities as it develops the next generation of digital therapeutics that help provide interventions for addressing critical unmet needs in the area of women’s mental health.

“We are extremely excited to have such amazing experts joining us at Curio,” said Chief Executive Officer Dr. Shailja Dixit. “Their contributions will be absolutely vital in our ever-growing mission to help women manage their behavioral health.”

Curio is pioneering the development of digital therapeutics designed specifically for women across their life cycle.

The Stella platform is the company’s first product for management of depression and anxiety for women who are pregnant or have recently delivered.

“There is a large unmet need when it comes to women’s behavioral health and we are thrilled to be working with such a highly respected cohort of scientific experts in their respective fields to accelerate our advancements to address those needs,” said Dr. Eliza Ng, MD, MPH, Chief Medical Officer.

The new members of Curio’s Scientific Advisory Board include:

Maria Cristina Canavarro, PhD, Haita Makanji, PhD, Gayathree Murugappan, PhD, Ana Fonseca, PhD, Catherine Monk, PhD, and Christina Smith, M.D.